SBI Term Loan: RLLR: 8.15 | 7.25% - 8.55%
Canara Bank: RLLR: 8 | 7.15% - 9.85%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.35% - 10.75%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 7.35% - 9.6%
IndusInd Bank: RLLR: -- | 7.6% - 10%
Bank of Maharashtra: RLLR: 8.05 | 7% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%
HDFC Bank: RLLR: -- | 7.75% - 13.2%
Axis Bank: RLLR: -- | 8% - 9.1%
IDBI Bank: RLLR: -- | 7.4% - 10%

Novonesis to invest INR 6,600 crore in Maharashtra’s Patalganga enzyme plant

#Infrastructure News#Industrial#India#Maharashtra
Synopsis

Danish biosolutions company Novonesis will invest INR 6,600 crore to expand its enzyme manufacturing facility at Patalganga in Maharashtra over the next four years. The expanded plant is expected to become fully operational by 2030 and will manufacture enzymes for industries such as biofuels, household care, food and beverages. The investment will help the company cater to rising demand across emerging markets, including India, the Middle East, Africa and South Asia. Novonesis also plans to reduce water and energy consumption at the facility through freshwater recycling and integrated heat pump systems.

Danish biosolutions producer Novonesis on Wednesday announced an investment of INR 6,600 crore in Maharashtra’s Patalganga to expand its enzyme manufacturing plant over the next four years. 
The expanded facility is expected to be fully operational by 2030 and will manufacture enzymes used across industries including biofuels, household care, and food and beverages, according to the company. 
Novonesis President and CEO Ester Baiget said the investment will help the company meet growing demand from emerging markets such as the Middle East, Africa, India and South Asia. She noted that these markets account for an important and expanding share of the company’s business and are expected to grow faster than developed markets in the coming years. 
Chief Operating Officer Anders Lund said locating additional capacity at Patalganga will bring the company closer to its customers while improving its scale, operational resilience, efficiency and supply flexibility. 
The company has previously invested in plant expansions in Thailand, the US and Brazil as part of its capital expenditure programme. 
Krishna Mohan Puvvada, regional president for the Middle East, India and Africa at Novonesis, said the Indian government’s BioE3 policy could help unlock the economic, social and environmental potential of biosolutions. 
Novonesis said the expanded facility will be designed to use less water and energy. Freshwater recycling will reduce the amount of water drawn by the plant, while integrated heat pumps will lower the energy needed for operations. 
The Patalganga facility was originally commissioned in 2019 by Novozymes. Novozymes later merged with Chr. Hansen in 2024, resulting in the formation of Novonesis. 
Patalganga, located on the outskirts of Mumbai, is an established industrial area with several chemical and petrochemical facilities. It is home to Reliance Industries’ first plant as well as facilities operated by Hindustan Organic Chemicals, Cipla and Asian Paints, among other companies. 
Source PTI

Discussion

Have something to say? Post your comment